Key result
Review outlines optimal adjunctive antithrombotic regimens for complex PCI.
Why the study?
Optimal adjunctive antithrombotic regimens for patients undergoing complex PCI remain undefined despite increased procedural complications and adverse outcomes.
This review summarizes recent evidence on antithrombotic therapies for patients undergoing complex PCI, an area where optimal regimens remain undefined.
Optimal antithrombotic regimens for complex PCI remain undefined; leaves open dedicated RCTs to guide practice.
Percutaneous coronary intervention (PCI) has remarkably evolved in the last decades. This has resulted in a larger number of patients treated with PCI, including those with more complex anatomic lesions. Several studies demonstrated that PCI involving complex lesions is associated with increased rate of procedural complications and adverse clinical outcomes. In this setting, optimal adjunctive antithrombotic regimens still need to be defined. In this review, we sought to summarize and discuss the recent evidence deriving from analyses appraising antithrombotic therapies in patients undergoing complex PCI.
No takes yet. Share an insight, caveat, or question.
Luca et al. (2020) conducted a review in Complex percutaneous coronary intervention. Antithrombotic therapies was evaluated. This review summarizes recent evidence on optimal adjunctive antithrombotic regimens for patients undergoing complex percutaneous coronary intervention.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: